058820.KS · CMG제약
South Korea · RS rating 3 · As of 2026-10-14
| Price | 562.00 KRW |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 25 / 4 / 4 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 14 / 38 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +1300.0% |
| Sales growth Q/Q | +10.8% |
| Distance from 52-week high | +73.7% |
| Market cap (USD) | $62.0M |